ASCO Power Technologies announces that SourcePacT™, the first Source Isolation Switch to enable Battery Energy Storage Systems (BESS) to provide emergency power to critical loads, is now the first ...

JCO CCI is an interdisciplinary and borderless journal publishing clinically relevant research based on biomedical informatics methods and processes applied to cancer-related data, information, and ...

In amongst the big clinical trial readouts at ASCO, a new research project made ... omics’, which combines gene sequencing with imaging technologies to analyse RNA and proteins not just for ...

Two impressive studies in lung cancer and another in breast cancer made Sunday a stellar day for AstraZeneca at the ASCO congress. Three of the group’s top cancer drugs were on display – EGFR ...

The findings, presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on Sunday 2 June, involved analysing blood samples from the ChemoNEAR sample collection study for ...

The goal of this internal strategy is to define how the United Nations system will support the use of new technologies like artificial intelligence, biotechnology, blockchain, and robotics to ...

A new study released to coincide with World Cancer Research Day today argues that wider access to clinical trials of new ...

A large trial of people with earlier stages of prostate cancer compared two types of external radiation treatments ...

Medical meetings often feature important clinical trial results, making them barometers of biotech and pharma companies' research progress. Here’s a list of conferences to watch in 2025.

JCO is the primary forum of scientific discourse for the American Society of Clinical Oncology (ASCO). Published three times a month, JCO is the foremost peer-reviewed journal focusing on clinical ...

FDA approves first-of-its-kind new ‘bubble’ treatment for liver cancer - Histotripsy could cause less harmful side effects ...